These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36336520)

  • 1. Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation.
    Ashman J; Mutsonziwa N; Romano M; Kordasti S; Lombardi G; Shangaris P
    Blood Rev; 2023 May; 59():101030. PubMed ID: 36336520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
    Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
    Front Immunol; 2021; 12():662048. PubMed ID: 34084166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
    Ding L; Zhu H; Yang Y; Yan HM; Zhang HH; Han DM; Wang ZD; Zheng XL; Liu J; Zhu L; Mei-Xue ; Guo ZK; Wang HX
    Leuk Res; 2017 May; 56():13-20. PubMed ID: 28161606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
    Taylor PA; Panoskaltsis-Mortari A; Swedin JM; Lucas PJ; Gress RE; Levine BL; June CH; Serody JS; Blazar BR
    Blood; 2004 Dec; 104(12):3804-12. PubMed ID: 15292057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes.
    Le Texier L; Lineburg KE; MacDonald KP
    Int J Hematol; 2017 Feb; 105(2):153-161. PubMed ID: 27943115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.
    Mahr B; Unger L; Hock K; Pilat N; Baranyi U; Schwarz C; Maschke S; Farkas AM; Wekerle T
    PLoS One; 2016; 11(1):e0146245. PubMed ID: 26731275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
    Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
    J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation.
    Zhao HY; Lyu ZS; Duan CW; Song Y; Han TT; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    Br J Haematol; 2018 Sep; 182(5):679-692. PubMed ID: 29974948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease.
    Hippen KL; Hefazi M; Larson JH; Blazar BR
    Front Immunol; 2022; 13():926550. PubMed ID: 35967386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD.
    Landwehr-Kenzel S; Müller-Jensen L; Kuehl JS; Abou-El-Enein M; Hoffmann H; Muench S; Kaiser D; Roemhild A; von Bernuth H; Voeller M; Schmueck-Henneresse M; Gruhn B; Stervbo U; Babel N; Volk HD; Reinke P
    Mol Ther; 2022 Jun; 30(6):2298-2314. PubMed ID: 35240319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD150
    Hirata Y; Furuhashi K; Ishii H; Li HW; Pinho S; Ding L; Robson SC; Frenette PS; Fujisaki J
    Cell Stem Cell; 2018 Mar; 22(3):445-453.e5. PubMed ID: 29456159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hematopoietic and leukemia stem cells by regulatory T cells.
    Riether C
    Front Immunol; 2022; 13():1049301. PubMed ID: 36405718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
    Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
    Front Immunol; 2020; 11():181. PubMed ID: 32117306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.
    Biswas CS; Sauter CT; Bailey CP; Rittenberg D; Luo X; Panis MM; Budak-Alpdogan T; Grosso D; Flomenberg N; Alpdogan O
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1808-18. PubMed ID: 23084958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.